Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Hanover Marc Steven
Relationship:   Chief Executive Office...
City:   Memphis
State:   TN
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   124,362    

Indirect Shares

  47,687      
Direct Value   $42,606    

Indirect Value

  $16,338      
Total Shares   172,049      
Total Value   $58,944      


Oncternal Therapeutics Inc
 $42,606 Oncternal Therapeutics Inc
 $42,606
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Oncternal Therapeutics Inc ONCT Chief Executive Office... 2018-01-05 124,362 2018-01-05 47,687    Premium*  
* Premium Members only  

Records found :    33         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ONCT Oncternal Therapeutics In... Chief Executive Officer   •       •      –    2016-01-14 4 B $0.47 $1,377 D/D 2,900 1,193,311 2.73 -
ONCT Oncternal Therapeutics In... Chief Executive Officer   •       •      –    2016-01-15 4 B $0.49 $10,889 D/D 22,100 1,215,411 2.81 -
ONCT Oncternal Therapeutics In... Chief Executive Officer   •       •      –    2016-01-19 4 B $0.50 $12,428 D/D 25,000 1,240,411 2.81 -
ONCT Oncternal Therapeutics In... Chief Executive Officer   •       •      –    2016-01-25 4 B $0.63 $8,067 D/D 12,813 1,253,224 2.81 -
ONCT Oncternal Therapeutics In... Chief Executive Officer   •       •      –    2016-01-26 4 B $0.65 $2,600 D/D 4,000 1,257,224 2.73 -
ONCT Oncternal Therapeutics In... Chief Executive Officer   •       •      –    2016-10-14 4 A $0.81 $99,999 D/D 123,456 1,380,680 0 -
ONCT Oncternal Therapeutics In... Chief Executive Officer   •       •      –    2018-01-01 4 D $12.71 $81,306 D/D (6,397) 131,671 0 -
ONCT Oncternal Therapeutics In... Chief Executive Officer   •       •      –    2018-01-05 4 S $11.13 $82,845 D/D (7,309) 124,362 0 -

  33  Records found
  1   2     
  Page 2 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed